Evaluation of the Effectiveness of Self Management Program on Changes in Physical Activity Level of Knee Osteoarthritis Patients in Spa Therapy

Knee Osteoarthritis Clinical Trial

— GEET One  

Official title:

Evaluation of the Effectiveness of Self Management Program on Changes in Physical Activity Level of Knee Osteoarthritis Patients in Spa Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02598804
• Other study ID #: CHU-251
• Secondary ID: 2015-A00831-48
• Status: Completed
• Phase: N/A
• First received: November 5, 2015
• Last updated: November 22, 2017
• Start date: July 2015
• Est. completion date: January 15, 2017

Study information

• Verified date: November 2017
• Source: University Hospital, Clermont-Ferrand
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary purpose is to evaluate the benefit of an education action of exercise on the level of physical activity in patients with knee osteoarthritis with the waning of a spa treatment for three weeks, three months after the start of the cure.

Description:

The aim of this study is to prove the effectiveness of an educational intervention in thermal environment on physical activity level with knee osteoarthritis patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 172
• Est. completion date: January 15, 2017
• Est. primary completion date: January 15, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients, male or female, aged 50 to 75 years.

• Patients with knee osteoarthritis clinical criteria of the American College of Rheumatology (ACR)

• Patient affiliated to a social security scheme (beneficiary entitled)

• Patient registered spa

• Patient has given its consent in writing to

Exclusion Criteria:

Related Conditions & MeSH terms

• Education
• Exercise
• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee
• Physical Activity
• Self-management

Intervention

Other:
• 5 educational workshop

• written information booklet

Locations

Country	Name	City	State
France	CHU Clermont-Ferrand	Clermont-Ferrand

Sponsors (3)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand	Clermont Communauté, Innovatherm

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Level of physical activity at 3 month, with score on IPAQ Short form		at 3 months
Secondary	Self efficacy at 3 months with score on ASES		at 3 months
Secondary	Functional status at 3 months with score on WOMAC		at 3 months
Secondary	Fears and beliefs at 3 months with score on KOFBeQ		at 3 months
Secondary	Pain at 3 months with score on EVA		at 3 months
Secondary	Sarcopenia at 18 days		at 18 days